Quadrant Capital Group LLC Has $2.72 Million Position in Dr. Reddy's Laboratories Limited (NYSE:RDY)

Quadrant Capital Group LLC increased its holdings in Dr. Reddy's Laboratories Limited (NYSE:RDY - Free Report) by 435.5% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 172,009 shares of the company's stock after buying an additional 139,886 shares during the period. Quadrant Capital Group LLC's holdings in Dr. Reddy's Laboratories were worth $2,716,000 as of its most recent filing with the Securities and Exchange Commission.

Several other institutional investors have also made changes to their positions in the stock. Townsquare Capital LLC acquired a new stake in Dr. Reddy's Laboratories during the third quarter worth about $286,000. Quantinno Capital Management LP increased its stake in Dr. Reddy's Laboratories by 18.0% in the third quarter. Quantinno Capital Management LP now owns 20,237 shares of the company's stock valued at $1,608,000 after acquiring an additional 3,094 shares during the last quarter. State Street Corp lifted its stake in Dr. Reddy's Laboratories by 1.9% during the third quarter. State Street Corp now owns 909,905 shares of the company's stock worth $72,292,000 after purchasing an additional 16,641 shares during the last quarter. Orion Portfolio Solutions LLC boosted its holdings in shares of Dr. Reddy's Laboratories by 43.2% in the 3rd quarter. Orion Portfolio Solutions LLC now owns 20,524 shares of the company's stock valued at $1,631,000 after purchasing an additional 6,192 shares in the last quarter. Finally, EWA LLC bought a new position in shares of Dr. Reddy's Laboratories in the 3rd quarter valued at $899,000. 3.85% of the stock is currently owned by institutional investors.

Wall Street Analyst Weigh In

Separately, Nomura cut shares of Dr. Reddy's Laboratories from a "buy" rating to a "neutral" rating in a research report on Thursday, December 19th.

Dr. Reddy's Laboratories Trading Up 3.1 %

RDY stock traded up $0.40 during trading on Friday, hitting $13.11. The company had a trading volume of 1,148,299 shares, compared to its average volume of 1,392,794. The company has a current ratio of 1.92, a quick ratio of 1.38 and a debt-to-equity ratio of 0.02. Dr. Reddy's Laboratories Limited has a one year low of $12.26 and a one year high of $16.89. The business has a 50-day moving average of $13.21 and a 200-day moving average of $14.38. The stock has a market cap of $10.94 billion, a PE ratio of 20.87 and a beta of 0.51.

Dr. Reddy's Laboratories (NYSE:RDY - Get Free Report) last issued its quarterly earnings results on Thursday, January 23rd. The company reported $0.20 earnings per share for the quarter, topping analysts' consensus estimates of $0.19 by $0.01. Dr. Reddy's Laboratories had a return on equity of 17.87% and a net margin of 17.25%. Research analysts predict that Dr. Reddy's Laboratories Limited will post 0.8 earnings per share for the current fiscal year.

Dr. Reddy's Laboratories Profile

Dr. Reddy's Laboratories Limited, together with its subsidiaries, operates as an integrated pharmaceutical company worldwide. It operates through Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), and Others segments. The company's Global Generics segment manufactures and markets prescription and over-the-counter finished pharmaceutical products that are marketed under a brand name or as a generic finished dosages with therapeutic equivalence to branded formulations, as well as engages in the biologics business.